RU93045704A - PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENT - Google Patents

PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENT

Info

Publication number
RU93045704A
RU93045704A RU93045704/14A RU93045704A RU93045704A RU 93045704 A RU93045704 A RU 93045704A RU 93045704/14 A RU93045704/14 A RU 93045704/14A RU 93045704 A RU93045704 A RU 93045704A RU 93045704 A RU93045704 A RU 93045704A
Authority
RU
Russia
Prior art keywords
lysinchlonixinate
analgesis
producing
application
inflammatory agent
Prior art date
Application number
RU93045704/14A
Other languages
Russian (ru)
Other versions
RU2108787C1 (en
Inventor
Е.М.Васкес Карлос
Original Assignee
Роммерс С.А.И.С.Ф.
Filing date
Publication date
Application filed by Роммерс С.А.И.С.Ф. filed Critical Роммерс С.А.И.С.Ф.
Priority to RU93045704A priority Critical patent/RU2108787C1/en
Priority claimed from RU93045704A external-priority patent/RU2108787C1/en
Publication of RU93045704A publication Critical patent/RU93045704A/en
Application granted granted Critical
Publication of RU2108787C1 publication Critical patent/RU2108787C1/en

Links

Claims (1)

Мягкие желатиновые капсулы с наполнителем, содержащим лизинхлониксинат в качестве активного ингредиента гидрофильной матрицы. Капсулы, согласно изобретению, обладают длительным сроком хранения и более быстрым терапевтическим эффектом при оральном приеме. Гидрофильная матрица содержит полиэтиленгликоль со средней мол. м. 200 - 1000 или смесь указанного полиэтиленгликоля с пропиленгликолем и/или пропиленкарбонатом, 3 - 10 мас.% глицерина и 15 мас. % воды. Мягкие желатиновые капсулы могут применяться в качестве болеутоляющих или противовоспалительных средств.Soft gelatin capsules with a filler containing lysine chloronixinate as the active ingredient of the hydrophilic matrix. Capsules according to the invention have a longer shelf life and a faster therapeutic effect when taken orally. The hydrophilic matrix contains polyethylene glycol with an average mol. m. 200 - 1000 or a mixture of the specified polyethylene glycol with propylene glycol and / or propylene carbonate, 3 to 10 wt.% glycerol and 15 wt. % water. Soft gelatin capsules can be used as painkillers or anti-inflammatory drugs.
RU93045704A 1993-09-01 1993-09-01 Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing RU2108787C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93045704A RU2108787C1 (en) 1993-09-01 1993-09-01 Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93045704A RU2108787C1 (en) 1993-09-01 1993-09-01 Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing

Publications (2)

Publication Number Publication Date
RU93045704A true RU93045704A (en) 1996-11-10
RU2108787C1 RU2108787C1 (en) 1998-04-20

Family

ID=20147697

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93045704A RU2108787C1 (en) 1993-09-01 1993-09-01 Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing

Country Status (1)

Country Link
RU (1) RU2108787C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130009553A (en) * 2011-07-15 2013-01-23 한미약품 주식회사 Capsule formulation comprising montelukast or a pharmaceutically acceptable salt thereof, and levocetirizine or a pharmaceutically acceptable salt thereof

Similar Documents

Publication Publication Date Title
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
ATE65023T1 (en) PHARMACEUTICAL AGENT.
CA2164933A1 (en) Methods for Aiding Periodontal Tissue Regeneration
CA2232310A1 (en) Stable compositions containing n-propargyl-1-aminoindan
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
CA2320039A1 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
DE3872199D1 (en) PHARMACEUTICAL COMPOSITIONS.
EP0382066A3 (en) Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent
CY1106542T1 (en) METHOD OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATINE PRESCRIPTIONS
DE69321596T2 (en) ESTERS AND COMBINATIONS OF AN ORGANIC NITRATE AND A SALICYCLATE
FI870457A0 (en) PHARMACEUTICAL FORM FOR STABILIZATION OF THE INTERFERENCE.
ITMI913170A1 (en) PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE CONTAINING A NON-STEROID ANTI-INFLAMMATORY AND A DECONGESTANT AS ACTIVE INGREDIENTS
ATE253354T1 (en) CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
ES2039377T3 (en) A SUPPOSITORY.
RU93045704A (en) PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENT
WO1999008666A3 (en) Pharmaceutical composition comprising an azateroid
UA40636C2 (en) pharmaceutical composition containing, as the active ingredient, an association of acetylsalicylic acid and metoclopramide, pharmaceutical medication in the form of powder and method for its preparation
EP0351897A3 (en) Skin penetration system for salts of amine-functional drugs
JPS5750914A (en) Betamethasone external pharmaceutical
ATE136778T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING DAPIPRAZOLE
RU93004785A (en) SOLID CAPSULES OF CITARABIN OXPHOSPHATE
CA2182812A1 (en) Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
KR940000108A (en) Pharmacological soft capsules containing lysine clonicsinate and method for preparing the same
KR960003717A (en) Use of elliprodil and its enantiomers for the manufacture of a medicament useful for the prevention of peripheral neuropathy caused by anticancer agents
FR2547730B1 (en) HYPOLIPIDEMIC DRUG CONTAINING AS ACTIVE INGREDIENT D-3-ACETOXY-CIS-2,3-DIHYDRO-5- (2- (DIMETHYLAMINO) ETHYL) -2- (P-METHOXYPHENYL) -1,5-BENZOTHIAZEPINE-4 (5H) -ONE OR ONE OF ITS SALTS OF ADDITION OF ACIDS ACCEPTABLE IN PHARMACY